tissue,gender,age,strain,cell type,treatment,cell line,sex,disease,genotype,time
# of tissue = 36 tissue,gender (mouse),age of plants,b virus strain,cell type (immunophenotype),age (at the end of treatment),human cell line,newborn sex,disease-free survival (dfs),12q13 genotype rs7136702,survival time (months)
4 months tissue,gender of human sera,age at biopsy,listeria strain,cell type subset,order of treatment,dendritic cell lineages,donor sex,disease free interval (days),9q24 genotype rs10975552,rna degradation time
prostate tissue,gender of mice,age at diagnosis (y),paternal strain,cell type subpopulation,vernalization treatment,or cell line,baby's sex,disease-free interval (months),15q13 genotype rs4779584,10years followup time (months)
# of tissue = 1 tissue,gender (rat),age (at diagnosis),siv strain,cell type (sorted),time (days of dss treatment),huh7 cell line,proband sex,disease duration (yrs),10p14 genotype rs706771,circadian time
# of tissue = 40 tissue,gender (sex),sac age (wks),bxd strain,sarcoma and primary cell type,period of treatment,hybrid cell line,apparent sex,disease free survival (months),rs5995355 genotype,survival time (month)
# of tissue = 42 tissue,gender of baby,age (1#pfu_1),donor strain,cell type/growth condition,duration of treatment (hours),tumor cell line,mouse sex,diseaseduration(years),20p12 genotype rs50005940,hybridization time
fetal vs adult tissue,gender,taqman pool by age,recipient strain,cell type/line,euthanasia day post treatment,atcc cell line,ctl bone 64 years  sex,disease activity (das28_v3),nod2 genotype,bddm followup time (months)
# of tissue = 38 tissue,gender and age,age at op,insect strain,cell type origin,day of dox treatment,host cell line,patient sex,mean disease duration,16q22 genotype rs2059254,survival time in months
a.thaliana tissue,gender of the clone,age of epilepsy duration (yr),pathogen strain,cell type [c],time after treatment,donor cell line,cell sex,disease relapse (event),8q24 genotype rs10505477,circadian time point
age of ffpe tissue,gender (pup),age of rat,host strain,b cell type,period of salt treatment,fibrosarcoma cell line,w sex,disease_free_survival_event,8q24 genotype rs7014346,circadian time (ct)
day of tissue dissection,gender composition,age of ffpe block (years),parasite strain,cell type(s),day of dss treatment,insect cell line,sexed,disease_free_survival_years,12q13 genotype rs11169544,sulfur deprivation time
age and tissue,adnp+/- gender,age of mouse,cell strain,cell types,time post treatment,es cell line type,sexual maturity,disease activity (das28_v1),hemoglobin genotype,drug treatment time
8 weeks. tissue,gender (male/female),age at examination,parental strains,host cell type,age at start of treatment,responder cell line,sex of recipient mice,disease_severity,pool genotype,4-thiouracil labeling time
sample tissue of origin,female gender,age-at-examination,source strain,cell type,days after treatment,stable cell line,sex (0-male 1-female),disease progression (event),individual genotype,partial hepatectomy time point
host tissue,mc3 gender,age at diagnosis,b.bifidum strain,t cell type,time to treatment (days),background cell line,sexual differentiation,trg disease state,8q23 genotype rs16892766,hcg treatment time
tumor tissue,mc2 gender,age (1#pvu_1),b.breve strain,cell type derived from,days of ddc treatment,cell line/clone,sex,code disease-specific survival,18q21 genotype rs7226855,meiotic time point
treated tissue,gender (1#pfu_2),age of trees,inbred strain,cell type (human),rai stage before treatment,reference cell lines,sex (male.1_female.2),disease free survival (month),20q13 genotype rs4925386,growth time points
somatic tissue,gender (1#pfu_1),age at primary diagnosis,hcmel3 strain,pancreatic cell type,weeks after treatment,coriell cell line,sex of donor mice,disease causing mutation,nqo1 rs1800566 genotype,light timepoint
gingival tissue phenotype,mc5 gender,age-at-biopsy-years,viral strain,cultured cell type,weeks of treatment,parental cell line,sexual_orientation,disease_onset,rs7575840 genotype,virus replication time
original tissue,mc4 gender,age of ffpe tissue,hcmv strain,targeted cell type,duration of il-6 treatment,ips cell line,sex (gender),age at disease onset,1q41 genotype rs6691195,il4 stimulation time
source tissue,mc1 gender,age (1#pfu_2),progeny strain,test cell type,time after h2o2 treatment,es cell line,sex (0-female 1-male),disease free interval (months),rs1333049 genotype,growth time
origin tissue,mc6 gender,age of sampling,parent strain,cancer cell type,days of treatment,injected cell line,sex of patient,disease severity,rs7956957 genotype,drug treatment time point
landrace tissue,host gender,age of epilepsy onset (yr),parental strain,melanoma cell type,duration of treatment,rcc cell line type,sex chromosome complement,disease category,8q24 genotype rs6983267,meiotic timepoint
original tissue source,ma2 gender,age of mice (wk),fish strain,background cell type,time (weeks of treatment),leukemia cell line,#NAME?,disease-state,14q22 genotype rs11623717,metastasis time (month)
primary tissue,strain c57bl/6  gender,age of biopsy,host strain background,other cell types,drug treatment time,primary cell line,sex chromosome ploidy,disease extension,1q41 genotype rs11579490,kcl treatment time (hours)
pig tissue,strain c57bl/6 gender,age of ipi (yr/mo),pythium strain,sorted cell type,rna treatment,cell line source age,sex/age,diseasestate,lrrk2 genotype,tnfa treatment time point
sample tissue type,ma4 gender,mother's age (years),maternal strain,source of cell type,5-aza-c treatment,cell line stably expresses,genotyped sex,disease status of patient,rnasel r462q genotype,sirna treatment time point
donor tissue,ma5 gender,maternal age (year),ehec strain,primary cell type,dac treatment,cell line (derived),recipient sex,disease progression,3q26 genotype rs12638862,nitrogen starvation time
brain tissue,ma3 gender,maternal age (yrs),cmv strain,tumor cell type,hcg treatment time,cell line nih code,sex/age at diagnosis (years),disease stage,genotype/varitaion,overall survival time_days
mammary tissue,ma1 gender,host age (yr),reference strains,source cell type,nature of treatment,cell line background,sex/mating type,disease subtype,genotype/variaton,cell harvest time
cell tissue,ma6 gender,age ≥ 65,congenic strain,tissue or cell type,valproate treatment,cell lines,,disease severity/outcome,maternal genotype/variation,collection timepoint
source tissue type,source gender,age of gestation,evolved strain,,ddc treatment,cell line specificity,,disease development,genotype/varat,cross-linking time
source  tissue,xenograft recipient gender,age-at-onset,test strain,,oligo treatment,cell line manufacturer,,diseasestatus,pathogen genotype/variation,continuous light time
harvested tissue type,donor gender,age (postnatal days),mice strain,,plant treatment,cell line source tissue,,disease outcome,genotype/variataion,mnase digestion time
fresh tissue,subject gender,age at death (years),vaccine strain,,drug treatment time point,cell line number,,disease_status,genotype/variations,collected time
tissue separation,cell line source gender,age at blood withdrawal,t cell strain,,units of treatment repeat,cell line source gender,,disease state (host),genotype/ variation,cell collection time
tissue & age,mouse model gender,age in vitro,back ground strain,,kcl treatment time (hours),cell line provider,,disease_state,genotype/varation,collection time
tissue factor,strain gender,age at death (in years),bacteria strain,,dsrna treatment,cell line ebv-status,,disease type,parental genotype/variation,conjugation time
tissuer type,fetus gender,age at collection,strain/background,,light treatment,cell line of origin,,disease,cmv genotype/variation,cell sorting time
tissue_detail,patient gender,age at sampling,basal strain,,tap treatment,cell line stably expressing,,disease course,host genotype/variation,overall survival time
tissue derivation,recipient gender,age_at_diagnosis,autoimmune strain,,b12 treatment,cell line specifics,,disease phenotype,paternal genotype/variation,4su labeling time
tissue,donor's  gender,age group (years),host mouse strain,,treatment/exposure,cell line or clinical sample,,disease status,genotype/background,pos-harvest time
tissue/treatment id,,age (month),bacterial strain,,bl treatment level,cell line description,,disease phase,rb genotype/variation,timepoint/developmental stage
tissue origination,,age@dx,immune strain/background,,dsrna treatment (knockdown),cell line origin,,disease location,genotype/variaion,postnatal time-point
tissue id,,age (pup),control strain o157,,rnai treatment,cell line passage,,diseased,tissue genotype/variation,evolution time (years)
tissue site,,average age,yeast strain,,antibody treatment,cell line,,disease exposure,genotype/variation,post-injury time
tissue_mg,,age_diag,bacterial strain used,,dht treatment,cell line traits,,disease/cell type,genotype/variation (host),post-infection time points
tissue subtype,,age harvested (days),host/mouse strain,,h2o2 treatment level,cell line population,,disease progression status,genotype/varaiation,post serum time point
tissue_biological,,age (after birth),m. tuberculosis strain,,units of treatment time,cell line karyotype,,disease state (phenotype),genotype/variation (offspring),developmental time
tissue processing,,age (days),mouse model strain,,post-dac treatment,cell line lineage,,disease group,genotype p53,post-infection time
tissue treatment,,age at sacrifice,mouse strain,,art treatment,cell line type,,disease state,genotype(breed),developmental time point
tissue (donor),,age description,equivalent strain name,,anti-cd8 treatment,cell line (sorted),,disease model,genotype = gs(1)n441 (mat,lps exposure time
tissue pair,,age category,plant strain,,tzd treatment,cell line reference,,subject's disease state,genotype of pollen,post-treatment time
tissue.origin,,age at sample (months),organ-derived dc strain,,dox treatment,cell line subpopulation,,primary disease,genotype icsbp1,expression time hours
tissue grade,,age high salt diet commenced,rrf-3 mutant strain,,amykor treatment,cell line (coriell id),,aggressiveness of disease,genotypes,event time (years)
tissue isolated,,age of  culture,animal/plant strain or line,,probiotic treatment,cell line derivation,,disease/treatment status,genotype.variation,post-mixing time
tissue preservation,,age/gender,toxplasma gondii strain,,ms treatment,cell line source ethnicity,,chief disease,genotype of the cells,post-exposure time
tissue type,,age at diagonosis (years),fibroblast cell strain,,chx treatment,cell line tissue source,,other diseases,genotype (transgenic line),post radiation time (hour)
tissues,,age(yrs.),eri-1 mutant strain,,uv treatment,cell line name,,lung disease,genotype,incubation time (hours)
tissue (brain region),,age seedlings,toxoplasma strain,,dna treatment,cell line id,,twin's disease state,genotype/ecotype,age/disease timepoint
tissue status,,age.brain,jackson lab. strain,,l-dopa treatment,cell line(s),,source disease,genotyped sex,infection_control time
tissue harvest,,age of the clone,secondary host strain,,tamoxifen-citrate treatment,cell lineage,,lyme disease stage,genotype/genetic variation,incubation time
tissue_source,,age at death (y),transgenic strain,,route of treatment,cell line characteristics,,dead of disease,genotype reference,diet intervention time
tissue_code,,age.blood,background mouse strain,,hours treatment,cell line/cell type,,celiac disease,genotype (brdt),injected timepoint
number of pooled tissues,,age at blood drawing (months),background strain(s),,pbmc treatment,cell line initiation date,,advanced disease stage,genotype of ecat15-1,infection time
tissue region,,age (weeks of gestation),toxoplasma parasite strain,,ntg treatment,cell line source,,chronic diseases,genotype rb,differentiation timepoint
tissue and developmental stage,,age at surgery,background strain,,in vitro treatment,cell line conditioning,,residual disease,genotype abbreviation,differentiation time days
tissue-cy3,,age(years),human cytomegalovirus strain,,h2o2 treatment,cell line resistance,,disease-resistance,genotype of ecat15-2,infection time (min)
tissue of origin,,age diet commenced,background strains,,chip dna treatment,cell line/type,,ocular disease,genotype variation,injection timepoint
tissue-cy5,,age at diagnosis (months),p. syringae pv tomato strain,,drb treatment,cell line/genotype,,advanced disease state,plant genotype,differentiation time
tissue or cells,,age of diagnosis (year),xenograft recipient strain,,ligand treatment,human colon cancer cell line,,clinical disease stage,hd genotype,doubling time
tissue harvest site,,age unit,strain for c57bl/6,,co2 treatment,human leukemia cell line,,source disease status,transgene genotype,feeding time
tissue ph,,developmental age,strain c57bl/6  gender,,lps treatment (time),originating cell line,,patient disease status,host soybean genotype,brain ph at time of freezing
tissuet type,,age (years at surgery),strain c57bl/6 gender,,prior treatment,origin of a cell line,,disease resistance,backgroud genotype,survival time (year)
tissue harvested,,age (postnatal day),strain y3724,,s2 treatment,source cell line,,residual disease (cm),esr1 genotype,survival time (years)
tissue_grade,,age at sacrafice,strain by4741 ptc5,,experimental treatment,ovarian cancer cell line,,hiv disease status,atf2 genotype,doubling time (hrs)
tissue bank,,development age,strain by4741 ptc51,,il-2 treatment,growth pattern of cell line,,donor disease state,infection (e. coli genotype),os time
tissue histology,,age time point,strain by4741 ptc2,,heat treatment,virus isolation cell line,,meibomian gland disease state,meis1 genotype,dfs time (yrs)
tissue (group),,age at blood draw,strain/cell-line,,drug treatment,,,etiology of liver disease,background genotype,agent time
tissue section,,agegroupatsampledraw,strain by4741 ptc1,,tamoxifen treatment,,,status of disease,brca genotype,fu time
tissuetype,,age.at.surgery,strain by4741 ptc4,,lithium treatment,,,duration of disease (month),idh1/2 genotype,pfs time
tissue [transplant],,ageofoperation,strain y3403,,tet1/tet2 treatment,,,stage of disease,th-mycn mouse genotype,os time (years)
tissue_depot,,ageatrecruitment,strain by4741 ptc3,,msc treatment,,,stage of disease (inss),myostatin genotype,pfs time (years)
tissue-type,,age at radiation,strain sr957,,adjuvant treatment,,,duration of disease,sdad2 genotype,zt time
tissue weigth,,agedx,strain sr959,,length of treatment (days),,,extent of disease,spea2 genotype,dss time
tissue-of-origin,,age  (months),strain (cy5),,treatment dose u/ml,,,,offspring genotype,dfs time (months)
tissue origin of cancer cell,,age (pn postnatal days),strain of the clone,,treatment_dose_u/ml,,,,precipitated ctcf genotype,dmfs time
tissue lineage,,age and tissue,strain duplicate (a or b),,length of treatment,,,,braf genotype,dfs time
tissue enriched for,,age at metastases,strain sr954,,vaccine or treatment,,,,host genotype,dark timepoint
tissue collection method,,age (days old),strain description,,cancer treatment,,,,tet2 genotype,dsn time
tissue extraction,,agenotype,strain source,,imatinib treatment,,,,strain genotype,time_after_resection
tissue source,,#NAME?,strain sr753,,environmental treatment group,,,,genotype/treatment,ex vivo challenge time
tissue or cell type,,age at irradiation,rat strain,,sirna or shrna treatment,,,,rb1 genotype,time of treatment
tissue derived,,age [y],strain (genetic background),,cytokine treatment,,,,hcv genotype,follow up time (months)
tissue part,,age at collection months,strain sr595,,specific treatments,,,,il4r genotype,time of treatment with fk866
tissue (pup),,age/disease timepoint,strain jlrela,,bioremediation treatment,,,,per3 genotype,time after media shift
tissue archive,,age put on diet,strain (mouse),,patient treatment,,,,host/mouse genotype,follow-up time (months)
tissue typ,,gender and age,strain y2197,,hnf4 si rna treatment,,,,bacterial genotype,full time pregancy
tissue sub-type,,age at collection (months),strain of maternal pronucleus,,gefitinib treatment,,,,prdm1 genotype,elapsed time
tissue preserve method,,age_group,strain info,,treatment/growth condition,,,,hla-dqb1 genotype,treatment time
tissue preparation,,age at 1st diagnosis,strain 1783,,tissue treatment,,,,mecp2 genotype,treatment time-point
tissue sample,,age of diagnosis,strain,,tnfa treatment time point,,,,apoe genotype,culture time
tissue collection time,,age (yrs) at dasatinib start,strain 1785,,cactus host treatment,,,,hal genotype,handling time
tissue_surgery,,age in 1986,strain 877 = mata wpl-9pk,,inducer treatment,,,,tbx1 genotype,treatment time (hours)
tissue storage,,age at tumor,strain recipient,,oxygen treatment,,,,e2f1 genotype,seizure time
tissue source site,,age at blood sample collection,strain or line,,sirna treatment group,,,,hdh genotype,stress time
tissue stage,,ageyear,strain 3235 = scc1-pk3,,treatment/sample type,,,,maternal genotype,relapse time
tissue diagnosis,,age quit smoking,strain y2468,,patient treatment plan,,,,relevant genotype,cold ischemia time (hours)
tissue archive method,,age months,strain sjl(%),,maternal treatment group,,,,gp130 genotype,culture time (hrs)
tissuebank,,age induced (days),strain of mouse,,small molecule treatment,,,,a.thaliana genotype,sk-mel-103 time
tissue estradiol conc.,,age at dx in days,strain number,,transfection or treatment,,,,mouse genotype,treatment time (rhgaa)
tissue morphology,,age at death,strain [background],,vaccine treatment,,,,ndrg1 genotype,cultivated time
tissue provider,,age in years,strain tw1,,globin treatment,,,,,culture doubling time
tissue (organ),,age (mouse),strain 379 = scc1-ha6,,compound based treatment,,,,,exposure time
tissue age,,age(month),strain y3071,,testosterone treatment,,,,,harvested time after dose
tissue region enriched for,,age (day),strainorline,,time of tamoxifen treatment,,,,,harvest time
tissue condition,,age_at_blooddraw,strain (or line),,in vivo treatment with,,,,,harvest time point
tissue subregion,,age at incident,strain backgroud,,hygromycin treatment,,,,,harvested at what time
tissue location,,age (bin),strain sr1187,,iodine treatment,,,,,treatment time point
tissue state,,age (years),strain origin,,ca04 or pbs treatment,,,,,cold ischemia time
tissue collection,,age at infection (yrs),strain (host),,dasatinib treatment,,,,,recovery time
tissue harvest methods,,age.at.diagnosis,1996). strain cd4ko (rrp6,,growth condition and treatment,,,,,sacrifice time
tissue compartment,,age at start,strain with gal,,response to treatment,,,,,harvest time after exposure
tissue origin,,age_at_onset,strain (rat),,dopamine-agonists treatment,,,,,ischemic time (days)
tissue_type,,age at operation (yrs),strain genotype,,c local treatment,,,,,treatment time(minutes)
tissue/sector,,agestatus,strain (of recipient mice),,secondary treatment duration,,,,,reperfusion time
thyroid tissue type,,age at operation,strain y3272,,response to tzd treatment,,,,,treatement time
tissue/tumor subtype,,age at onset,strain name,,preoperative treatment,,,,,induction time (hours)
tumor tissue source,,agender,strain y3351,,time of treatment,,,,,induction time (h)
secondary lymphoid tissue,,age (mos),strain y2460,,chemical treatment condition,,,,,injection time
tissue genotype/variation,,ageatdiagnosis,strain b6(%),,enrichment treatment,,,,,stimulation time
tissue/origin,,age of culture,strain jam1,,chemical treatment conditon,,,,,sampling date and time
tissue/source,,agedecade,strain y2699,,ecdysone treatment,,,,,training timepoint
tissue/cell type,,age at surgery (yrs),strain of ooplasm,,myo-inositol treatment,,,,,sampling time (hours)
tissue/cell,,age_tx,strain/cell line background,,cardioglycoside treatment,,,,,split ratio time 1
tissue/cell lines,,age_enroll,strains,,growth factor treatment,,,,,fermentation time point
tissue/cell line,,ageatsampling,strain_description,,ionizing radiation treatment,,,,,hatching time
tissue/cell preparation,,age of embryo,strain phenotype,,hormone treatment,,,,,sample time point
tissue/cell line [c],,age (yr),strain (yeast),,immunogen treatment,,,,,fermentation time
tissue/cell  type,,age of subjects,strain donor,,hormonal treatment,,,,,survival time
connective tissue type,,age (year),strain sr453,,animal treatment,,,,,sampling time point
tissue/developmental stage,,age_dx,strain tw14,,stress treatment,,,,,donation time
cell line source tissue,,age at vaccination,strain dba2(%),,dnase treatment,,,,,extraction time
tissue/development stage,,age at infection,strain y3586,,rnase treatment,,,,,survival time (days)
cell line tissue source,,age at first birth,strain[background],,chloride treatment,,,,,sampling timepoint
,,age of blood draw,strain (cy3),,c systemic treatment,,,,,induction time
,,age in days at diagnosis,strain details,,bisulfite treatment of rna,,,,,stimulation time and condition
,,age (in years),strain (donor),,sirna treatment time point,,,,,sporulation timepoint
,,age of onset,strain by4741-msn2,,lenolidamide treatment,,,,,sample collection time
,,age at baseline,strain background,,sirna treatment,,,,,transfection time
,,age/weight,strain of paternal pronucleus,,intrusion treatment,,,,,ph<7.30 at time of diagnosis
,,age(yrs),strain/accession,,time of treatment with fk866,,,,,explant timepoint
,,ageatdraw,strain yjdi381 gal1-taf1,,doxycycline treatment,,,,,harvest timepoint
,,age.year,strain(s),,in vivo treatment,,,,,time of sorting
,,age group,strain id,,shrna treatment,,,,,time interval fromc (months)
,,ageunit,strain gender,,transcription factor treatment,,,,,time course
,,age_years,strain by4741-pho23,,post surgical treatment,,,,,time of biopsy
,,agebin,strain type,,cell treatment,,,,,time period
,,age at harvest,strain serotype,,chamber treatment,,,,,time clin rec
,,age at presentation,strain.rep,,peptide treatment,,,,,time of death
,,age (y),strain (e. coli),,acidification treatment,,,,,time sac
,,age at time of resection,strain by4741-rco1,,timepoint 4h treatment,,,,,time_point
,,agegroup,strain sr563,,sample treatment,,,,,time biopsy to surgery (days)
,,age post partum,strain by4741-rpd3,,b240 or saline treatment,,,,,time_to_metastasis (years)
,,age (months),strain y3650,,secondary treatment,,,,,time at 4ºc
,,age at 2nd diagnosis,strain by4741-ume6,,treatment.type,,,,,time of sampling
,,age of plant,strain fgsc number,,treatment2_in vivo treatment,,,,,time of hcmv infection
,,age (yrs),strain crl,,treatment time-point,,,,,time to outcome
,,average age (days after birth),strain/model,,treatment stage,,,,,time of day
,,age on study,strain/condition,,treatment regimen,,,,,time post bloodmeal
,,age (at weaning),strain/genotype,,treatment period,,,,,time (months) overall survival
,,age 4-7 years,strain/ecotype,,treatments,,,,,time post-surgery
,,age of source,strain/isolate,,treatment agent,,,,,time p.i.
,,age at diagnosis (years),strain/genotype variation,,treatment duration,,,,,time post-stimulation
,,age (yrs) at rrp,strain/genotyp,,treatment_molecule,,,,,time of pseudo-pregnancy
,,agegrp,infection (influenza strain),,treatment repeat,,,,,age at the time of surgery
,,age(years)/gender,strain/line,,treatment result,,,,,time after treatment
,,age diagnosis,virus strain,,treatment response in vitro,,,,,time_to_death (yr)
,,age of human sera,infection (virus strain),,treatment time (rhgaa),,,,,time of tamoxifen treatment
,,age of woman [years],infrequent clonal strain code,,treatment_2,,,,,time of growth
,,age/sex,infected with bacterial strain,,treatment_1,,,,,time since lif removal
,,age of the mice,,,treatment response in vivo,,,,,time of sample collection
,,age of onset (years),,,treatment duration (hours),,,,,time of followup (mo)
,,age bin,,,treatment_time,,,,,time (hr)
,,age at disease onset,,,treatment length,,,,,time after actd
,,ageing at 29 c in days,,,folate treatment,,,,,time trial
,,age sacrificed,,,treatment name,,,,,time (days of dss treatment)
,,age (yr-old),,,treatment of estrogen,,,,,time point (hr)
,,age at sacrifice (days),,,treatment adchem,,,,,time point in batch cycle
,,age,,,treatment (short label),,,,,time(weeks)
,,age of patient,,,treatment_dose,,,,,time until recurrence (years)
,,160!!!,,,treatment concentration,,,,,time to treatment (days)
,,control case age,,,treatment dosage,,,,,timepoint (dpa)
,,gestational age (wks),,,treatment [c],,,,,time after lights on
,,donor age (years),,,treatment_category,,,,,time (days post-treatment)
,,gestional age,,,treatment time point,,,,,time (post-inoculation)
,,gestational age at delivery,,,treatment pairs,,,,,time after scale removal
,,gestational age (w+d),,,treatment protocol,,,,,time period of attachment
,,donor age,,,treatment exposure,,,,,time bcr
,,embryo age,,,treatment 1,,,,,time (after crossing)
,,donor age (y),,,treatment_protocol,,,,,time_to_relapse (yr)
,,cycle phase/ gestational age,,,treatment time(minutes),,,,,time stimulated with anti-igm
,,gestational age (wk),,,treatment 2,,,,,time met rec
,,diagnosis age,,,treatment state,,,,,time in meiosis
,,patient age,,,treatment start age,,,,,time post-wound
,,patient age at diagnosis,,,treatment class,,,,,time post mcao before sample
,,gestational age,,,treatment condition,,,,,recurrence free time (months)
,,conidial age,,,treatment code,,,,,time sampled
,,donor's age,,,adjuvant patient treatment,,,,,time of surgery
,,hoechst- (viable) cells. age,,,treatment before sampling,,,,,time point
,,onset of age,,,treatment age,,,,,time_to_relapse (years)
,,gestational age of pups,,,treatment,,,,,time (weeks of treatment)
,,final age at death,,,treatments prior to dasatinib,,,,,time post vbg
,,patient age (yrs),,,nrti treatment status,,,,,timetofirstszmin
,,baseline age (years),,,treatment time,,,,,time to harvest
,,ctl bone age,,,treatment*,,,,,time recovery (hour)
,,subject age (years),,,treatment variable,,,,,time after feeding
,,biofilm age,,,treatment time (hours),,,,,time (d)
,,gestational age (weeks),,,treatment batch,,,,,time (of harvest)
,,op bone age,,,treatment status,,,,,time point (minutes)
,,embryonic age,,,treatment category,,,,,time (wpi)
,,subject age,,,treatment description,,,,,time graft
,,postnatal age,,,treatment of mouse,,,,,relapse free survival time
,,animal age,,,treatment type,,,,,time point after stress
,,mc6 age,,,treatment_given,,,,,time reference
,,gallus gallus  - age,,,treatment amount [c],,,,,time of sacrifice
,,cell line source age,,,treatment_schedule,,,,,time point (visit)
,,ma3 age,,,treatment arm,,,,,time post-induction
,,mc1 age,,,treatment_response,,,,,time point [c]
,,cell age,,,treatment route,,,,,time in constant white light
,,ma6 age,,,treatment delivery,,,,,time-point
,,mc3 age,,,treatment drug,,,,,time point (min)
,,wild-type (col-0) age,,,treatments comments,,,,,time point (day)
,,medicago (truncatula)  - age,,,treatment-time,,,,,time differentiated
,,mc5 age,,,treatment (chemo),,,,,time of transfection
,,age (at the end of treatment),,,treatment dose,,,,,time inject
,,age (at specimen collection),,,treatment group,,,,,time [h]
,,in a diurnal environment. age,,,treatment of the mice,,,,,time_to_progression
,,age at dx,,,treatment response,,,,,time [hours]
,,age at enrollment (years),,,treatment gp,,,,,time in meiosis (hr)
,,age at the time of surgery,,,treatment_time[hr],,,,,time (post-treatment)
,,age at time of surgery,,,treatment compound,,,,,time after lesion (days)
,,age at start of treatment,,,,,,,,time (hours)
,,age [years / days],,,,,,,,time.to.recurrence (years)
,,age (month) at surgery,,,,,,,,time (duration)
,,age at onset (years),,,,,,,,time post transplant
,,age at dx (years),,,,,,,,time extraction
,,age_at_prostatectomy_(years),,,,,,,,time_to_dod_(months)
,,age at start of experiment,,,,,,,,time clinical recurrence
,,age (in days post-partum),,,,,,,,time (h) post-infection
,,age at start therapy,,,,,,,,time after surgery
,,initial age (infection day),,,,,,,,timepoint (wks)
,,age at excision (years),,,,,,,,time pi (weeks)
,,age at rc,,,,,,,,timecollected
,,mutant age,,,,,,,,time of exposure
,,tissue & age,,,,,,,,age at time of surgery
,,ma4 age,,,,,,,,time point (days)
,,ma5 age,,,,,,,,time to distant metastasis
,,sampling age,,,,,,,,time after inoculation
,,pig age,,,,,,,,time of exercise
,,mean age in days,,,,,,,,time after induction[days]
,,source age,,,,,,,,time.to.death (years)
,,neuron age,,,,,,,,time point (post-inoculation)
,,plant age,,,,,,,,time2lr
,,mean age years (range),,,,,,,,time under flooding (h)
,,units of age,,,,,,,,time injected
,,mc4 age,,,,,,,,time (min.)
,,mouse age,,,,,,,,time (post-injection)
,,ma2 age,,,,,,,,time (hpi)
,,proband age,,,,,,,,time post-mrsa infection
,,infant age,,,,,,,,time (relative to induction)
,,age(weeks),,,,,,,,time of harvest
,,fetus age,,,,,,,,timesampletaken
,,age (weeks),,,,,,,,time since wetting
,,ma1 age,,,,,,,,time (hours after pollination)
,,mouse model age,,,,,,,,time (days post-infection)
,,sample age group,,,,,,,,time rfs
,,tissue age,,,,,,,,time
,,age range,,,,,,,,time aed
,,sample age,,,,,,,,time of collection
,,mc2 age,,,,,,,,time submerged
,,mean age,,,,,,,,time (h)
,,recipient age,,,,,,,,timepoint (hrs)
,,culture age,,,,,,,,time pfs (months)
,,median age,,,,,,,,time after induction
,,maternal age,,,,,,,,time point (hrs)
,,estimated age,,,,,,,,time_hr_post_hypoxia
,,current age (2007),,,,,,,,time (minutes)
,,paternal age,,,,,,,,time to recurrence (years)
,,treatment start age,,,,,,,,time after infection
,,starting age,,,,,,,,time since sample1 months
,,culture age (days),,,,,,,,time (incubation)
,,treatment age,,,,,,,,time post-vaccination
,,not current age,,,,,,,,time class
,,serum culture age,,,,,,,,time (post-protocol)
,,vitis (41528 population) - age,,,,,,,,time in hrs
,,cell culture age,,,,,,,,time post-injection
,,,,,,,,,,time of embryo collection
,,,,,,,,,,time quit (@ initial consult)
,,,,,,,,,,time after h2o2 treatment
,,,,,,,,,,time after injury (hours)
,,,,,,,,,,time (min)
,,,,,,,,,,time (post virus infection)
,,,,,,,,,,time post exposure
,,,,,,,,,,time post-copulation
,,,,,,,,,,time after isolation
,,,,,,,,,,time [post-infection]
,,,,,,,,,,time(absolute)
,,,,,,,,,,time post surgery
,,,,,,,,,,time no bcr
,,,,,,,,,,time since meiosis started
,,,,,,,,,,time measured post wounding
,,,,,,,,,,time post-inoculation
,,,,,,,,,,age time point
,,,,,,,,,,time of cacrifice
,,,,,,,,,,time after vaccination
,,,,,,,,,,time (days)
,,,,,,,,,,time os (months)
,,,,,,,,,,time [days of culture]
,,,,,,,,,,time of gut bacteria
,,,,,,,,,,time after es/ga (days)
,,,,,,,,,,time post infection
,,,,,,,,,,time fter actd
,,,,,,,,,,biopsy time
,,,,,,,,,,time to outcomel
,,,,,,,,,,time point (week end)
,,,,,,,,,,time post injury
,,,,,,,,,,time metastatic recurrence
,,,,,,,,,,time after adoptive transfer
,,,,,,,,,,time_in_freezer
,,,,,,,,,,time point after hepatectomy
,,,,,,,,,,time on diet
,,,,,,,,,,time post-immunization
,,,,,,,,,,time points
,,,,,,,,,,time post-perforation
,,,,,,,,,,timepoint 4h treatment
,,,,,,,,,,time before sampling
,,,,,,,,,,time to survival
,,,,,,,,,,time after induction [days]
,,,,,,,,,,time sample taken
,,,,,,,,,,time in continuous light
,,,,,,,,,,timepoints
,,,,,,,,,,time (dpi)
,,,,,,,,,,time-to-progession (months)
,,,,,,,,,,time post-infection
,,,,,,,,,,time (post amputation)
,,,,,,,,,,time after plating
,,,,,,,,,,time of euthanasia
,,,,,,,,,,time to hcc recurrence (days)
,,,,,,,,,,time of sample harvesting
,,,,,,,,,,time post-dox
,,,,,,,,,,time point post-infection
,,,,,,,,,,time of differentiation
,,,,,,,,,,time after transfection (hr)
,,,,,,,,,,time in spo (hours)
,,,,,,,,,,timepoint (weeks)
,,,,,,,,,,time exposure
,,,,,,,,,,time after stimulation
,,,,,,,,,,time post treatment
,,,,,,,,,,timesincemating
,,,,,,,,,,time point (hours)
,,,,,,,,,,time point (h)
,,,,,,,,,,time in culture
,,,,,,,,,,time after exposure
,,,,,,,,,,time (hrs)
,,,,,,,,,,time point (months)
,,,,,,,,,,time-points collected
,,,,,,,,,,age at time of resection
,,,,,,,,,,time pre_post surgery (years)
,,,,,,,,,,time (post-infection)
,,,,,,,,,,time of specimen collection
,,,,,,,,,,time and stimulation
,,,,,,,,,,time after infection (h)
,,,,,,,,,,time in fr light
,,,,,,,,,,time sacrificed
,,,,,,,,,,time(wpi)
,,,,,,,,,,time_hpi
,,,,,,,,,,time of relapse
,,,,,,,,,,time after injury
,,,,,,,,,,time in entraining conditions
,,,,,,,,,,time to death (mos)
,,,,,,,,,,tissue collection time
,,,,,,,,,,time.to.ok
,,,,,,,,,,timeunit
,,,,,,,,,,time to next relapse(days)
,,,,,,,,,,time post transfection
,,,,,,,,,,time to meta or recurrence
,,,,,,,,,,time of progression
,,,,,,,,,,time_rec (years)
,,,,,,,,,,time of atoh1 expression
,,,,,,,,,,time post injection
,,,,,,,,,,time post-treatment
,,,,,,,,,,time (doxorubicin)
,,,,,,,,,,timepoint
,,,,,,,,,,sample time after surgery
,,,,,,,,,,sampling time group
,,,,,,,,,,sampling time
,,,,,,,,,,secondary time course
,,,,,,,,,,sample time
,,,,,,,,,,units of treatment time
,,,,,,,,,,units of harvest time point
,,,,,,,,,,time f/u
